NCT06885541 Detection of Internal Tremors by Oscillometry in Parkinson's Patient
| NCT ID | NCT06885541 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2027-05-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-10 with a primary completion date of 2027-05-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the present study is to objectively access the presence of an Internal Tremor in Parkinson's disease. Inertial sensors will be used to detect the presence of a rhythmic oscillation of 3-4 Hz. The study will be performed in both Parkinson's disease patients and healthy controls to ascertain the specificity of this type of tremor.
Eligibility Criteria
Inclusion Criteria: (For the experimental group) * Patient with idiopathic parkinson's disease * Mini Mental State Evaluation score above or equal to 25 * Hoehn and Yahr scale score of ≤3 in the OFF phase, with postural stability allowing the patient to stand unaided for 1 minute. * Able to walk unassisted * Willing to undergo accelerometry in the OFF state (For the control group) * Healthy volunteer subjects matched for age (+/- 5 years) and sex * Mini Mental State Evaluation score above or equal to 25 Exclusion Criteria: (For the experimental group) * Patients with an atypical parkinsonian syndrome * Patients unable to walk or stand for more than one minute in the off state * Parkinson's patients treated with deep brain stimulation, apomorphine pump, or duodopa intestinal infusion, and foslevodopa * Pregnant patients * Major osteoarticular problems * Neurological condition that may affect gait (For the control group) * Participants with significant gait impairment (osteoarticular disorder) * Those with a neurological disease that, in the investigator's judgment, may interfere with the study's outcome measure * Participants with a clinical tremor that may interfere with the measurement of the primary outcome (e.g., essential tremor, thyroid disease, or tremors induced by medication) * Pregnant participants
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06885541 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06885541 currently recruiting?
Yes, NCT06885541 is actively recruiting participants. Contact the research team at pinheirobarbosa.ar@chu-toulouse.fr for enrollment information.
Where is the NCT06885541 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT06885541 clinical trial?
NCT06885541 is sponsored by University Hospital, Toulouse. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.